2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Mark Gladwin: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multi-Center Study of Riociguat in Patients With Sickle Cell Diseases Riociguat, Placebo - Sickle Cell Disease | Phase 2 | Completed | Mark Gladwin | 130 | 2017-04-11 | 2023-07-19 |
| Storage Lesion in Banked Blood Due to Disruption of Nitric Oxide (NO) Homeostasis Acetylcholine and Blood - Healthy | Phase 1 | Completed | Mark Gladwin | 53 | 2010-04-01 | 2015-04-14 |
Acetylcholine (1) · Blood Specimen Collection (1) · riociguat (1)
United States (2)
PMID 26222884, PMID 34889382, PMID 38554715
R01HL098032 (1)